Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia
The licensing of oral semaglutide provided a step forward in type 2 diabetes management for this group, and the publication of the SOUL study in 2025 reassured us that oral semaglutide could also offer cardiovascular benefit in those at highest risk
That cautious curiosity turns into an urgent question: what are the real risks and evidence gaps behind microdosing, and why do they matter so much now
Evans et al., PNAS 99: 13801-6, (2002))
While B12 is involved in metabolism and energy production, there is limited evidence to support its use as a weight-loss aid alone
L-Tyrosine Some find L-tyrosine life changing, others find it useless, Learn more about this intervention